Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

CNS 4Sarcoma 2Lymphoid 2Other hematologic neoplasm 1Myeloid 1

Conditions

Glioma 3Glioblastoma 3Astrocytoma 2Recurrence 1Oligodendroglioma 1Medulloblastoma 1Gliosarcoma 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Tetanus Toxoid × CNS × Clear all
NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed
175 enrolled 18 charts
CNS

Glioblastoma, Glioma

NCT00639639 2023-03-13

ATTAC

Duke University

Phase 1 Completed
42 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02747407 2021-10-29

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

Wake Forest University Health Sciences

Completed
55 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT03615404 2021-01-28

ATTAC-P

Duke University

Phase 1 Completed
11 enrolled 7 charts
CNS

Astrocytoma, Glioblastoma, Glioma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡